The FDA, through its 503B program, authorizes compounding pharmacies to make non-generic drugs that are listed in shortage, such as semaglutide currently. But watching this space evolve ...

Semaglutide is a generic medication. Its brand names are approved for the treatment of type 2 diabetes and obesity. Compounded semaglutide is not FDA-approved, could come with risks, and may lead ...

Researchers discovered semaglutide—the active ingredient in Ozempic and Wegovy—may reduce the risk of death and lower the chance of developing cardiovascular conditions like stroke and heart ...

MADRID — In a rat study, two versions of an experimental monthly injectable semaglutide-loaded hydrogel show extended release over 1 month and good tolerance. If found to be safe and effective ...

Around one in seven Medicare beneficiaries with a high body mass index (BMI) may be newly eligible for semaglutide treatment after Medicare allowed Part D plans to cover the drug for patients with ...

But now more Medicare patients may be able to access semaglutide for weight loss. This spring, the CMS said it would cover the costs of Novo Nordisk’s Wegovy for some people with a history of ...

If you haven’t heard of semaglutide yet, there’s a lot to know about this medicine making waves in the world of health and wellness. Originally designed for type 2 diabetes, this medication is ...

According to a study published today in Annals of Internal Medicine, expanding Medicare coverage for semaglutide could make millions of older Americans newly eligible for the drug, but with the ...

Doctors have called GLP-1 medications — including semaglutide brand names Ozempic and Wegovy — “miracle drugs” for weight loss, offering a potential solution to Tennessee’s obesity ...

A new study finds a significant correlation between the use of semaglutide drugs such as Ozempic, antidepressant, or benzodiazepine use, and suicidal ideation. No such link was found between ...

In a recent study published in JAMA Network Open, researchers investigate the potential link between the obesity drugs semaglutide and liraglutide and suicidal or self-injurious adverse drug ...